Zackary S. Irani - 12 Dec 2025 Form 4 Insider Report for BIOMERICA INC (BMRA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
31 Dec 2025, 17:10:06 UTC
Prior SEC filing
17 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Zackary S. Irani

Key filing fact

Zackary S. Irani filed Form 4 for BIOMERICA INC (BMRA) on 31 Dec 2025.

Key facts

  • This page summarizes Zackary S. Irani's Form 4 filing for BIOMERICA INC (BMRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 31 Dec 2025, 17:10.

Change

  • Previous filing in this sequence was filed on 17 Dec 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001282349 Primary reporting owner

Irani Zackary S.

Relationship
Chief Executive Officer, Director
Address
17571 VON KARMAN AVE, IRVINE
Signature
/s/ Zackary S. Irani
Signature date
31 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BMRA transaction

Common stock

Award

Transaction value
$0
Shares
+52,500
Change %
+33%
Price
$0.000000
Shares after
211,320
Date
12 Dec 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest over 4 years at 25% on each anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .